Molecular Research of Neurodegenerative and Psychiatric Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: closed (15 June 2023) | Viewed by 27293
Special Issue Editors
Interests: molecular basis; genetics; psychiatric disorders; neurodegenerative diseases; pharmacogenetics; neurobiology; neuropharmacology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis and Huntington’s disease, as well as psychiatric diseases, such as schizophrenia, anxiety, depression and addictions, are multifactorial and heterogeneous disorders, which pose significant health, social and economic problems. Despite many studies, their complex etiology is still poorly understood, and therapeutic strategies are often limited to relieving their symptoms. The elucidation of their molecular background may contain keys for identifying risk factors, offering novel diagnostic or prognostic biomarkers, as well as providing novel and specific targets for their prevention and treatment. This Special Issue aims to present the most up-to-date findings regarding research targeting molecular mechanisms underlying different neurodegenerative and psychiatric diseases. It aims to provide a broad overview of novel advances in the field, including studies at the molecular, epi/genetic and cellular levels, but will also cover integrative, imaging and psychopharmacology research areas, as well as comprehensive omics approaches. We welcome the submission of studies using various preclinical in vitro and in vivo models, as well as clinical studies involving human subjects.
Dr. Dubravka Švob Štrac
Dr. Matea Nikolac Perkovic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative disorders
- psychiatric diseases
- biomarkers
- therapeutic targets
- omics approaches
- molecular pathways
- cell biology
- animal models
- clinical studies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.